Aerosol Masks Market Size Worth $63.7 Billion By 2030: IndustryARC

The Global Aerosol Masks Market size is predicted to reach $63.7 billion by 2030, growing at a CAGR of 7.3% during the forecast period 2024-2030 according to the latest market research report published by IndustryARC. The surging demand for aerosol masks to treat patients with respiratory problems caused by air pollution or viruses is poised to propel the market growth, finds IndustryARC in its recent report, titled “Aerosol Masks Market – By Type (Elongated, Standard), By Age Group (Adult, Pediatric), By End-user (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care, Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030.”

Request Sample Research Report: www.industryarc.com/pdfdownload.php?id=800502

Asia-Pacific is predicted to see the highest growth of 8% CAGR in the global market for aerosol masks between 2024 and 2030. In many areas of Asia-Pacific, air pollution is still a big issue, and people are becoming more aware of the health dangers linked to exposure to airborne pollutants. While this is one of the main factors influencing the demand for aerosol masks in Asia-Pacific. On 19 December 2022, WHO reported that combined effects of ambient air pollution and household air pollution are associated with 6.7 million premature deaths annually and 89% of those deaths occurred in low- and middle-income countries and the greatest number in the WHO South-East Asia region during the forecast period.

                                                                                                      

 

In congestive heart failure (CHF), fluid can accumulate in the lungs, leading to respiratory distress. In such cases, aerosol masks may be used to deliver diuretic medications that help reduce fluid buildup in the lungs and alleviate respiratory symptoms. Aerosol masks might be used post-operative recovery phase for oxygen intake, patients may experience respiratory challenges due to the effects of anesthesia or the surgical procedure itself. For instance, Centers for Disease Control and Prevention reported, one person dies every 33 seconds in the United States from cardiovascular disease. Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year.

Among the end-users, the ambulatory surgical centers (ASC) segment is analyzed to grow with the highest CAGR of 7.8% during the forecast period 2024-2030. Rising number of procedures performed in ASCs and the growing use of aerosol therapy in ASCs to deliver medication to the lungs, aerosol masks are being widely utilized in ASCs. The increasing cost of healthcare, the desire for shorter hospital stays and the convenience of having procedures performed in a non-hospital setting give rise to ASCs' popularity.

The North America region held the largest market share of $15.3 billion in 2023. There was already a significant demand for aerosol masks in the region due to the surge in respiratory illnesses since the COVID-19 pandemic. On top of that, the elderly population in North America has increased rapidly in the last two decades. As aging people are more likely to develop chronic respiratory diseases, they would require aerosol masks more for the treatment. According to the latest UN report, by 2050, one in four people in the United States will be aged 65 or over. Additionally, there is a growing awareness of the benefits of aerosol therapy among healthcare providers and patients in North America. These factors helped North America maintain its dominance in the aerosol masks market in 2023.

The increased demand for personalized masks is a major factor driving the growth of the aerosol masks market. Personalized masks are designed to fit the individual patient's face, which ensures a better seal and a more effective delivery of medication to the lungs. This can lead to improved patient outcomes and reduced side effects. The increased demand for personalized masks is expected to continue in the coming years. This is due to the continued growth of personalized medicine and the continued development of 3D printing technology.

 

The development of new delivery technologies is creating a massive opportunity for the aerosol masks market. These new delivery technologies can improve the efficacy and safety of aerosol therapy, increasing patient compliance and better results. Recent advancements in nanotechnology have enabled researchers to utilize nanoparticles as carriers for pulmonary drug delivery using aerosol-generating device. A recent article published by the National Library of Medicine highlights the challenges and strategies for translational research on inhalable nanoparticle-based dry powder formulations for respiratory diseases.

The growing demand for home healthcare is creating a major opportunity for the players in the aerosol mask market. Home healthcare is a type of care that is provided to patients in their homes. This type of care is becoming increasingly popular due to a number of factors, including the aging population, the growing prevalence of chronic respiratory diseases, and the rising cost of healthcare.

Companies can target specific patient populations, such as those with asthma, COPD, or cystic fibrosis. This can be done by developing masks that are specifically designed for these conditions. This is a great opportunity for market players to capitalize on the growing prevalence of respiratory diseases. According to CDC report, the U.S. has already witnessed at least 8.7 million illnesses, 78,000 hospitalizations and 4,500 deaths from flu since October 2022. To treat such respiratory illnesses, market players should develop aerosol masks for these specific conditions, which would drive the market growth further.

● Aerosol Masks Market Size and Forecast 

● Aerosol Masks Market Trends

● Aerosol Masks Market Analysis by Product Type

● CAGR of the market during the forecast period 2024-2030

● Value Chain analysis of key stake holders

● Detailed analysis of market drivers and opportunities during the forecast period

● Aerosol Masks Market size estimation and forecast

● Analysis and predictions on end users’ behavior and upcoming trends 

● Competitive landscape and Vendor market analysis including offerings, developments, and financials

● Comprehensive analysis of challenges and constraints in the Aerosol Masks Market

Due to the respiratory issues caused by COVID-19, aerosol mask demand has greatly grown, especially among critically sick patients who need breathing support. Healthcare professionals have been treating COVID-19 patients using aerosol masks and other respiratory gear because the virus is mostly disseminated by respiratory droplets. Another typical treatment for COVID-19 patients is oxygen therapy, which is administered via aerosol masks.

Aerosol masks are among the major medical items that Ukraine produces in large quantities. The manufacture and supply of these items are anticipated to be hampered as a result of the current conflict between Russia and Ukraine. Moreover, due to the respiratory problems brought on by military fighting and exposure to harmful chemicals, the war is predicted to increase demand for aerosol masks in both Russia and Ukraine. The market may also be negatively impacted by trade restrictions, currency volatility, and political unrest. 

To Get a Customized Industry Analysis, Speak with our Research Analyst: connect.industryarc.com/lite/schedule-a-call-with-our-sales-expert

 

The Global Aerosol Masks Market is fragmented with several global and regional companies operating with expansive manufacturing capabilities and extensive distribution networks. The key companies profiled are listed below:

● 3M Company

● Medline Industries, Inc.

● Teleflex Incorporated

● Smiths Medical, Inc.

● Vyaire Medical, Inc.

● Becton, Dickinson and Company

● ResMed Inc.

● Mercury Medical

● Armstrong Medical Industries, Inc.

● Intersurgical Ltd.

 

 

Aerosol Propellant Market – Aerosol Propellant market is projected to grow at a CAGR of 5.4% from 2021 to 2026, owing to increasing usage of aerosol propellants in various end-use industries such as automotive, medical, personal care, and more. 

Healthcare Equipment Market – The Healthcare Equipment Market is projected to grow at a CAGR of 4.6% during the forecast period from 2022 to 2027. The growth of this market is mainly attributed to surging applications of blood pressure monitors, patient monitors and heart rate monitors are projected to drive the growth of the healthcare equipment market and soaring innovations in healthcare equipment are expected to boost the growth of the healthcare equipment industry.

Asthma and COPD Devices Market – The Asthma and COPD Devices Market is growing at a CAGR of 4.9% during the forecast period. It is due to the increasing incidences of respiratory diseases and the growing technological advancements in the healthcare industry.  

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets.  

IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format which assists an intelligent and informed decision-making process.

 

Mr. Venkat Reddy

IndustryARC

Email: [email protected]

USA: (+1) 970-236-3677